VITROS SARS-CoV-2 Antigen Controls Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen

VITROS SARS-CoV-2 Antigen Controls Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen

The VITROS SARS-CoV-2 Antigen Controls Kit is intended for use in the immunodiagnostic determination of the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal and oropharyngeal swab samples using the enhanced chemiluminescence method on VITROS series analyzers, lot 0018.

Package Contents:

• Control 1 (Negative Control) – 3 vials, 3.0 ml each
• Control 2 (Positive Control) – 3 vials, 3.0 ml each
• Operating documentation for the medical device – 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, VITROS SARS-CoV-2 Antigen Controls Kit for Immunodiagnostic Detection of the SARS-CoV-2 Nucleocapsid Antigen, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.